PNC Financial Services Group
ARCT icon

PNC Financial Services Group’s Arcturus Therapeutics ARCT Stock Holding History

PNC Financial Services Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.17K Buy
1,058
+439
+71% +$3.2K ﹤0.01% 4042
2025
Q4 		$3.79K Buy
619
+481
+349% +$5.2K ﹤0.01% 4337
2025
Q3 		$2.54K Hold
138
– – ﹤0.01% 4437
2025
Q2 		$1.79K Buy
138
+85
+160% +$1K ﹤0.01% 4440
2025
Q1 		$561 Buy
53
+45
+563% +$714 ﹤0.01% 4616
2024
Q4 		$136 Hold
8
– – ﹤0.01% 4691
2024
Q3 		$186 Hold
8
– – ﹤0.01% 4685
2024
Q2 		$195 Sell
8
-12
-60% -$364 ﹤0.01% 4671
2024
Q1 		$675 Buy
+20
New +$709 ﹤0.01% 4445
2014
Q3 		– Sell
-143
Closed -$17K – 3974
2014
Q2 		$17K Hold
143
– – ﹤0.01% 2980
2014
Q1 		$18K Buy
+143
New +$21.2K ﹤0.01% 2873

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's ARCT Position: Q1 2026 in Review

PNC Financial Services Group increased its Arcturus Therapeutics (ARCT) stake by 71% in Q1 2026, buying an estimated $3.2K and bringing the position to 1,058 shares worth $8.17K. The position accounts for ﹤0.01% of the portfolio, ranked #4042.

PNC Financial Services Group first reported a position in ARCT in Q1 2014 and has held it in 11 quarters since. The position peaked at $18K in Q1 2014. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • PNC Financial Services Group held 1,058 shares of Arcturus Therapeutics worth $8.17K as of Q1 2026.
  • PNC Financial Services Group bought 439 Arcturus Therapeutics shares in Q1 2026, an estimated $3.2K.
  • Arcturus Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4042 holding.
  • PNC Financial Services Group first reported a position in Arcturus Therapeutics in Q1 2014 and has held it in 11 quarters since.
  • PNC Financial Services Group's Arcturus Therapeutics position peaked at $18K in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.